D-Wave Quantum Inc. filings document the regulatory record for a public quantum computing company that develops annealing and gate-model systems, software and services. The company’s Form 8-K disclosures include operating results, financial-condition updates, investor presentations, Regulation FD announcements, customer and collaboration developments, user conferences and product or technical updates.
Proxy and governance filings cover board matters, executive compensation, equity awards and shareholder voting items. Other material-event filings describe compensation arrangements, the company’s equity incentive plan, subsidiary agreements and formal disclosures tied to its commercial quantum computing business.
D-Wave Quantum Inc. director reports small stock purchase
A director of D-Wave Quantum Inc. (QBTS) reported buying 82 shares of common stock on 11/18/2025 at a price of $21.89 per share. These shares are held indirectly through the director's spouse.
After this transaction, the director reports 19,837 shares held directly, which includes 17,978 unvested restricted stock units, and 118,840 shares held indirectly through the West-Karam Family Trust, where the director is trustee and a beneficiary. The director formally disclaims beneficial ownership of the shares held by the spouse for certain legal purposes.
D‑Wave Quantum (QBTS) reported an insider transaction by its EVP, Chief Legal Officer & GC. On 11/13/2025, the officer sold 20,000 shares of common stock at a weighted average $23.6641 under a Rule 10b5‑1 plan adopted on August 14, 2025. The filing also notes a separate sale of 2,803 shares to cover taxes upon RSU vesting at a weighted average $23.1744.
Following these transactions, the reporting person beneficially owned 566,042 shares, which includes 224,613 unvested RSUs. Price ranges were disclosed as $23.00–$25.26 for the 20,000-share sale and $23.00–$23.435 for the sell‑to‑cover.
D-Wave Quantum Inc. (QBTS) insider activity: On 11/13/2025, President & CEO and Director Alan Baratz sold 168,102 shares of Common Stock in a mandated “sell to cover” related to RSU vesting to satisfy statutory tax withholding. The weighted average sale price was $23.1744, with trades between $23.00 and $23.435. Following the transaction, he beneficially owned 2,633,163 shares, which includes 735,087 unvested restricted stock units.
D-Wave Quantum (QBTS) filed a Form 4 for its CFO, John M. Markovich. On 11/13/2025, he sold 98,060 shares of Common Stock at a weighted average price of $23.1744. The filing states the sale was a mandated “sell to cover” to satisfy statutory tax withholding upon RSU vesting and was not a discretionary trade.
Following the transaction, he beneficially owns 1,482,874 shares, which include 545,315 unvested restricted stock units. Ownership is reported as direct.
D-Wave Quantum (QBTS) reported an insider transaction by President & CEO and director Alan Baratz. On 11/11/2025, he exercised stock options for 806,288 shares at $0.91 and sold 806,288 shares at a weighted average price of $28.8686 under a Rule 10b5-1 trading plan adopted on August 11, 2025. The sales occurred in multiple trades between $28.00 and $30.02.
Following the transactions, Baratz directly beneficially owned 2,801,265 shares, which includes 1,110,087 unvested restricted stock units. Derivative holdings reported after the transactions include options for 1,268,107 shares at $0.91 expiring on 05/05/2030, and options for 213,232 shares at $0.846 expiring on 01/10/2034.
D-Wave Quantum Inc. (QBTS) received a Form 144 notice indicating a proposed sale of up to 98,060 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 11/13/2025 and an aggregate market value of $2,272,482.
The filing lists recent equity acquisition via vesting of 218,750 RSUs on 11/13/2025 for services. It also discloses prior sales in the last three months, including 100,000 shares on 08/12/2025 for $1,800,000 and 50,000 shares on 09/10/2025 for $815,000. Shares outstanding were 346,720,000; this is a baseline figure, not the amount being offered.
D-Wave Quantum Inc. (QBTS) filed a Form 144 notice for a proposed sale of 168,102 shares of common stock, reflecting an aggregate market value of $3,895,664. The seller plans to sell on or about 11/13/2025 through J.P. Morgan Securities LLC on the NYSE.
The filing lists 346,720,000 shares outstanding as context. It also notes an acquisition of 375,000 shares on 11/13/2025 via vesting of restricted stock units for services rendered. Over the past three months, the person for whose account the securities are to be sold completed a sale of 31,369 shares on 10/14/2025 for $1,372,186 in gross proceeds.
D-Wave Quantum Inc. (QBTS) disclosed a Form 144 notice for the proposed sale of 2,803 Class A common shares through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 11/13/2025 and an aggregate market value of $64,957.86.
The seller reported acquiring 6,250 shares on 11/13/2025 via vesting of restricted stock units for services rendered. As context, shares outstanding were 346,720,000. Recent sales by the same person include 20,827 shares on 10/14/2025 for $911,044 and 69,270 shares on 08/13/2025 for $1,259,308.
D‑Wave Quantum (QBTS) stockholder filed a Form 144 notice to sell 40,000 shares of common stock through J.P. Morgan Securities LLC on or after 11/13/2025 via the NYSE. The notice lists an aggregate market value of $1,056,000.
The shares to be sold were acquired through an ESPP purchase on 06/30/2023 for 5,514 shares (cash) and an RSU vesting on 10/13/2023 for 34,486 shares. The filing also reports a prior sale in the last three months: 20,837 shares on 10/14/2025 for $911,044. Proceeds from any sales would accrue to the selling holder, not the company.
D-Wave Quantum Inc. announced it will redeem all outstanding public warrants at $0.01 per Warrant at 5:00 p.m. New York City time on November 19, 2025. Holders may exercise their Warrants until that deadline by contacting their broker; any Warrant not exercised by then will be void, with holders entitled only to the redemption price.
Each Warrant is exercisable for 1.4541326 shares of common stock for an aggregate cash price of $11.50 per Warrant, with any fractional share rounded down to the nearest whole share. The redemption right was triggered because the common stock traded at least $18.00 per share on 20 trading days within a 30‑day period, as required under the Warrant Agreement. The company expects November 17, 2025 to be the last NYSE trading day for the Warrants. The underlying shares are registered under an effective registration statement dated April 12, 2024.